Last Updated: 18/06/2024
Development of a novel point-of-care Plasmodium vivax dot-matrix antibody test to accelerate malaria elimination
Objectives
This project aims at developing a novel cost-efficient and field-deployable diagnostic test that recognises specific patterns in a person’s immune responses to malaria.
Principal Institution
Walter and Eliza Hall Institute of Medical Research (WEHI), Australia
Principal Investigators / Focal Persons
Rationale and Abstract
To efficiently eliminate P. vivax (Pv), malaria control programs needs tools to detect areas with ongoing transmission and to identify and treat people with dormant Pv liver infection. This test will expand the capacities of current rapid-diagnostic tests to detect not only current but also recent past infections.
External reference
Date
Jan 2020 — Dec 2022
Total Project Funding
$679,995
Funding Details
National Health and Medical Research Council (NHMRC) Australia, Australia
Grant ID: 1171795
AUD 978,263
Country / Project Site(s)
Related Resources
